Citation: | LIU Xinpei, MIAO Qi, LIU Jianzhou. Potts Shunt for Refractory Pulmonary Hypertension: Historical and Future Perspectives[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 313-317. DOI: 10.12290/xhyxzz.2021-0047 |
[1] |
Baruteau AE, Serraf A, Levy M, et al. Potts shunt in children with idiopathic pulmonary arterial hypertension: long-term results[J]. Ann Thorac Surg, 2012, 94: 817-824. DOI: 10.1016/j.athoracsur.2012.03.099
|
[2] |
D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry[J]. Ann Intern Med, 1991, 115: 343-349. DOI: 10.7326/0003-4819-115-5-343
|
[3] |
Rossano JW, Singh TP, Cherikh WS, et al. The Interna-tional Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report-2019; Focus theme: Donor and recipient size match[J]. J Heart Lung Transplant, 2019, 38: 1028-1041. DOI: 10.1016/j.healun.2019.08.002
|
[4] |
Rich S, Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. [J] Am J Cardiol, 1983, 51: 1560-1561. DOI: 10.1016/0002-9149(83)90678-1
|
[5] |
Cantor WJ, Harrison DA, Moussadji JS, et al. Deter-minants of survival and length of survival in adults with Eisenmenger syndrome[J]. Am J Cardiol, 1999, 84: 677-681. DOI: 10.1016/S0002-9149(99)00415-4
|
[6] |
Blanc J, Vouhe P, Bonnet D. Potts shunt in patients with pulmonary hypertension[J]. N Engl J Med, 2004, 350: 623. DOI: 10.1056/NEJM200402053500623
|
[7] |
Baruteau AE, Belli E, Boudjemline Y, et al. Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients[J]. Eur J Cardiothorac Surg, 2015, 47: e105-e110. DOI: 10.1093/ejcts/ezu445
|
[8] |
Lancaster TS, Shahanavaz S, Balzer DT, et al. Midterm outcomes of the Potts shunt for pediatric pulmonary hyperten-sion, with comparison to lung transplant[J]. J Thorac Cardiovasc Surg, 2021, 161: 1139-1148. DOI: 10.1016/j.jtcvs.2020.10.163
|
[9] |
Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT[J]. J Heart Lung Transplant, 2019, 38: 879-901. DOI: 10.1016/j.healun.2019.06.022
|
[10] |
Thangappan K, Morales DLS. Commentary: To transplant or not to transplant: Potts shunt as an alternative to pediatric lung transplantation[J]. J Thorac Cardiovasc Surg, 2021, 161: 1149-1150. DOI: 10.1016/j.jtcvs.2020.11.062
|
[11] |
Grady RM, Eghtesady P. Potts Shunt and Pediatric Pulmonary Hypertension: What We Have Learned[J]. Ann Thorac Surg, 2016, 101: 1539-1543. DOI: 10.1016/j.athoracsur.2015.08.068
|
[12] |
Sabi TM, Schmitt B, Sigler M, et al. Transcatheter creation of an aortopulmonary shunt in an animal model[J]. Catheter Cardiovasc Interv, 2010, 75: 563-569. http://new.med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_JJ0217568038
|
[13] |
Esch JJ, Shah PB, Cockrill BA, et al. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience[J]. J Heart Lung Transplant, 2013, 32: 381-387. DOI: 10.1016/j.healun.2013.01.1049
|
[14] |
Boudjemline Y, Patel M, Malekzadeh-Milani S, et al. Patent ductus arteriosus stenting (transcatheter Potts shunt) for palliation of suprasystemic pulmonary arterial hyperten-sion: a case series[J]. Circ Cardiovasc Interv, 2013, 6: e18-e20.
|
[15] |
Boudjemline Y, Sizarov A, Malekzadeh-Milani S, et al. Safety and Feasibility of the Transcatheter Approach to Create a Reverse Potts Shunt in Children With Idiopathic Pulmonary Arterial Hypertension[J]. Can J Cardiol, 2017, 33: 1188-1196. DOI: 10.1016/j.cjca.2017.06.004
|
[16] |
Ratnayaka K, Rogers T, Schenke WH, et al. Magnetic Resonance Imaging-Guided Transcatheter Cavopulmonary Shunt[J]. JACC Cardiovasc Interv, 2016, 9: 959-970. DOI: 10.1016/j.jcin.2016.01.032
|
[17] |
Bui MT, Grollmus O, Ly M, et al. Surgical palliation of primary pulmonary arterial hypertension by a unidirectional valved Potts anastomosis in an animal model[J]. J Thorac Cardiovasc Surg, 2011, 142: 1223-1228. DOI: 10.1016/j.jtcvs.2010.10.060
|
[18] |
Rosenzweig EB, Ankola A, Krishnan U, et al. A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: Early experience in adolescents and adults[J]. J Thorac Cardiovasc Surg, 2021, 161: 1438-1446. e2. DOI: 10.1016/j.jtcvs.2019.10.149
|
[19] |
Garekar S, Meeran T, Dhake S, et al. Valved reverse Potts shunt in a case of pulmonary hypertension due to pulmonary veno-occlusive disease[J]. Indian J Thorac Cardiovasc Surg, 2021, 37: 89-92. DOI: 10.1007/s12055-020-00993-2
|
[1] | LI Shuting, DONG Lili, YANG Xinlei, LÜ Lin, LIU Fukai. Exploratory Study on the Impact of Intestinal Fungi on the Progression of Heart Failure in Patients with Chronic Kidney Disease[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2025-0016 |
[2] | TIAN Kunling, CHEN Chuanning. Notch Signaling Pathway and Congenital Heart Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 649-654. DOI: 10.12290/xhyxzz.2023-0594 |
[3] | XU Fen, ZHOU Zhou. Heart Failure: Prevention and Treatment are Indispensable[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 953-957. DOI: 10.12290/xhyxzz.2022-0440 |
[4] | QIU Luhong, LIU Yingxian, XU Xiqi. Nonnegligible Myocarditis: Insights from 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 530-534. DOI: 10.12290/xhyxzz.2022-0077 |
[5] | XU Fen, ZHOU Zhou. Universal Definition and Classification of Heart Failure Triggers the Standardization of Diagnosis and Treatment of Heart Failure[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 621-623. DOI: 10.12290/xhyxzz.2021-0436 |
[6] | QIN Yongwen, BAI Yuan. History and Development of Interventional Devices forCongenital Heart Diseases in China[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 309-312. DOI: 10.12290/xhyxzz.2021-0148 |
[7] | XIAO Jiawang, ZHU Xianyang. Evolution of Interventional Treatment of Congenital Heart Disease in China[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 303-308. DOI: 10.12290/xhyxzz.2021-0157 |
[8] | AI Shanshan, HE Aibin. Advances in Basic Research of Congenital Heart Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 291-297. DOI: 10.12290/xhyxzz.2021-0055 |
[9] | ZHANG Hao, LI Shoujun, SU Zhanhao. Reflections on Improving the Diagnosis and Treatment of Congenital Heart Diseasein China: the Regionalization of Care for Congenital Heart Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 287-290. DOI: 10.12290/xhyxzz.20200280 |
[10] | Shuai HU, Zhi-yan HAN, Xiao-jian WANG, Jing-jun HAN, De-qiang WU, Lei ZHANG, Yan-gui LIN, Jian-wen LIANG, Wen-bin WEI, Wen-lin ZHANG, Cun-fu MU, Yi WANG, Dian-yuan LI. Monitoring Value of Central Venous Oxygen Saturation, the Substitute for Mixed Venous Oxygen Saturation, in Postoperative Care of Congenital Heart Disease with Pulmonary Arterial Hypertension:a Multicenter Prospective Study[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(3): 228-233. DOI: 10.3969/j.issn.1674-9081.2018.03.008 |